Invention Grant
- Patent Title: Kv1.3 potassium channel antagonists
-
Application No.: US15309781Application Date: 2015-05-07
-
Publication No.: US10370413B2Publication Date: 2019-08-06
- Inventor: Andreas Klostermann , Jörg Stockhaus
- Applicant: cgtx-Peptide Development GmbH
- Applicant Address: DE Martinsried
- Assignee: cgtx-Peptide Development GmbH
- Current Assignee: cgtx-Peptide Development GmbH
- Current Assignee Address: DE Martinsried
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: GB1408135.0 20140508
- International Application: PCT/EP2015/060073 WO 20150507
- International Announcement: WO2015/169901 WO 20151112
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/00 ; C07K7/00 ; C07K7/08 ; C07K14/705 ; C07K14/47
Abstract:
Compounds which selectively bind to and inhibit the activity of the potassium channel Kv1.3 are described. Pharmaceutical compositions comprising such compounds and the use of said compounds and said pharmaceutical compositions for the treatment or prevention of autoimmune diseases, obesity, parodontitis and/or tissue transplant rejection are also described.
Public/Granted literature
- US20170137470A1 Kv1.3 Potassium Channel Antagonists Public/Granted day:2017-05-18
Information query
IPC分类:
